Overview
Hong-xia Shi practices in Beijing, China. Shi is highly rated in 2 conditions, according to our data. Their top areas of expertise are Chronic Myelogenous Leukemia (CML), Leukemia, Polycythemia Vera, Acute Promyelocytic Leukemia, and Bone Marrow Transplant.
Their clinical research consists of co-authoring 52 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Myelogenous Leukemia (CML)
- LeukemiaShi isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Acute Promyelocytic Leukemia
- Blood ClotsShi isExperienced. Learn about Blood Clots.
- Bone Marrow TransplantShi isExperienced. Learn about Bone Marrow Transplant.
- Essential ThrombocythemiaShi isExperienced. Learn about Essential Thrombocythemia.